Delivery Order SPE2DB24D1104-SPE2DB25FXWD7
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D2104|SPE2DB25FMEGR, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,764.33, is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication. This appears to be a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was competitively...
This federal contract award, identified as SPE2DB20D3104|SPE2DB25FV4L4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,997.50 firm fixed-price delivery order is for the supply of 4566845521 VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 7, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2024. The $2,225.85 delivery order contract is for the supply of 4566514913 VYVANSE 50 MG CAPSULE 100S, a medication product. The contract has a firm fixed price and a completion date of November 22, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,053.46 firm fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of October 17, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a Delivery Order worth $1,783.60 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is for the provision of 4566588592 VYVANSE 30 MG CAPSULE 100S. The ultimate completion date is December 3, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,407.54 firm fixed-price delivery order covers the supply of VYVANSE 30 MG CAPSULE 100S, a medical commodity for the DLA. The contract has an ultimate completion date of November 6, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,485.36 delivery order contract is for the supply of VYVANSE 40 MG CAPSULE 100S, with an ultimate completion date of October 18, 2024. The contract has a firm fixed price pricing type and does not utilize any set-aside designation, indicating open competition.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,452.83 firm fixed-price delivery order is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,114.86 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a specialty medication. The contract has an ultimate completion date of November 20, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award, SPE2DB25D2204|SPE2DB25FTFXT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,173.83 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of 4566861069 - VYVANSE 20 MG CAPSULE 100S. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...